Adams Diversified Equity Fund’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-40,300
| Closed | -$16.3M | – | 109 |
|
|
2025
Q2 | $16.3M | Hold |
40,300
| – | – | 0.59% | 53 |
|
|
2025
Q1 | $20.1M | Hold |
40,300
| – | – | 0.8% | 41 |
|
|
2024
Q4 | $21M | Sell |
40,300
-7,800
| -16% | -$4.29M | 0.79% | 36 |
|
|
2024
Q3 | $29.8M | Sell |
48,100
-4,600
| -9% | -$2.72M | 1.09% | 17 |
|
|
2024
Q2 | $29.1M | Buy |
52,700
+12,000
| +29% | +$6.87M | 0.99% | 23 |
|
|
2024
Q1 | $23.7M | Hold |
40,700
| – | – | 0.84% | 45 |
|
|
2023
Q4 | $21.6M | Sell |
40,700
-7,200
| -15% | -$3.49M | 0.85% | 48 |
|
|
2023
Q3 | $24.2M | Sell |
47,900
-9,300
| -16% | -$4.96M | 1.04% | 35 |
|
|
2023
Q2 | $29.8M | Sell |
57,200
-19,400
| -25% | -$10.5M | 1.24% | 19 |
|
|
2023
Q1 | $44.1M | Hold |
76,600
| – | – | 1.98% | 8 |
|
|
2022
Q4 | $42.2M | Hold |
76,600
| – | – | 2.02% | 8 |
|
|
2022
Q3 | $38.9M | Buy |
76,600
+8,000
| +12% | +$4.48M | 1.94% | 7 |
|
|
2022
Q2 | $37.3M | Hold |
68,600
| – | – | 1.77% | 9 |
|
|
2022
Q1 | $40.5M | Hold |
68,600
| – | – | 1.61% | 12 |
|
|
2021
Q4 | $45.8M | Hold |
68,600
| – | – | 1.74% | 9 |
|
|
2021
Q3 | $39.2M | Buy |
68,600
+29,000
| +73% | +$15.9M | 1.55% | 11 |
|
|
2021
Q2 | $20M | Sell |
39,600
-49,400
| -56% | -$23.3M | 0.79% | 47 |
|
|
2021
Q1 | $40.6M | Hold |
89,000
| – | – | 1.74% | 10 |
|
|
2020
Q4 | $41.5M | Sell |
89,000
-4,800
| -5% | -$2.25M | 1.88% | 8 |
|
|
2020
Q3 | $41.4M | Hold |
93,800
| – | – | 2.02% | 8 |
|
|
2020
Q2 | $34M | Hold |
93,800
| – | – | 1.8% | 7 |
|
|
2020
Q1 | $26.6M | Hold |
93,800
| – | – | 1.68% | 9 |
|
|
2019
Q4 | $30.5M | Hold |
93,800
| – | – | 1.57% | 15 |
|
|
2019
Q3 | $27.3M | Buy |
93,800
+6,100
| +7% | +$1.75M | 1.46% | 19 |
|
|
2019
Q2 | $25.8M | Sell |
87,700
-42,700
| -33% | -$11.8M | 1.37% | 20 |
|
|
2019
Q1 | $35.7M | Hold |
130,400
| – | – | 1.96% | 9 |
|
|
2018
Q4 | $29.2M | Sell |
130,400
-15,000
| -10% | -$3.52M | 1.8% | 13 |
|
|
2018
Q3 | $35.5M | Hold |
145,400
| – | – | 1.76% | 14 |
|
|
2018
Q2 | $30.1M | Hold |
145,400
| – | – | 1.6% | 16 |
|
|
2018
Q1 | $30M | Hold |
145,400
| – | – | 1.64% | 14 |
|
|
2017
Q4 | $27.6M | Hold |
145,400
| – | – | 1.49% | 23 |
|
|
2017
Q3 | $27.5M | Hold |
145,400
| – | – | 1.49% | 20 |
|
|
2017
Q2 | $25.4M | Hold |
145,400
| – | – | 1.43% | 22 |
|
|
2017
Q1 | $22.3M | Hold |
145,400
| – | – | 1.28% | 27 |
|
|
2016
Q4 | $20.5M | Hold |
145,400
| – | – | 1.27% | 30 |
|
|
2016
Q3 | $21.5M | Hold |
145,400
| – | – | 1.44% | 24 |
|
|
2016
Q2 | $21.5M | Hold |
145,400
| – | – | 1.44% | 24 |
|
|
2016
Q1 | $20.6M | Buy |
+145,400
| New | +$19.5M | 1.43% | 27 |
|
Other funds holding TMO
Adams Diversified Equity Fund's TMO Position: Q3 2025 in Review
Adams Diversified Equity Fund sold out of Thermo Fisher Scientific (TMO) in Q3 2025, closing a stake of 40,300 shares — an estimated $16.3M sold.
Adams Diversified Equity Fund first reported a position in TMO in Q1 2016 and held it in 38 quarters. The position peaked at $45.8M in Q4 2021. 2,508 funds tracked by Wall St. Rank hold TMO as of Q3 2025.
- Adams Diversified Equity Fund reported no remaining Thermo Fisher Scientific position as of Q3 2025 after selling out during the quarter.
- Adams Diversified Equity Fund sold 40,300 Thermo Fisher Scientific shares in Q3 2025, an estimated $16.3M.
- Adams Diversified Equity Fund first reported a position in Thermo Fisher Scientific in Q1 2016 and held it in 38 quarters.
- Adams Diversified Equity Fund's Thermo Fisher Scientific position peaked at $45.8M in Q4 2021.
- 2,508 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.
Based on Adams Diversified Equity Fund's 13F filing for Q3 2025, filed 22 Oct 2025.